BACKGROUND: The inability to quantify sexual exposure to HIV limits the power of HIV prevention trials of vaccines, microbicides, and preexposure prophylaxis in women. We investigated the detection of HIV-1 and Y chromosomal (Yc) DNA in vaginal swabs from 83 participants in the HPTN 035 microbicide trial as biomarkers of HIV exposure and unprotected sexual activity. METHODS: One hundred forty-three vaginal swabs from 85 women were evaluated for the presence of Yc DNA (Quantifiler Duo DNA quantification kit; Applied Biosystems) and total HIV-1 DNA (single-copy in-house quantitative polymerase chain reaction assay). Y DNA detection was paired with self-reported behavioral data with regard to recent coitus (≤1 week before collection) and condom usage (100% vs. <100% compliance). RESULTS: Yc DNA was detected in 62 (43%) of 143 swabs. For the 126 visits at which both behavioral data and swabs were collected, Yc DNA was significantly more frequent in women reporting less than 100% condom usage (odds ratio, 10.69; 95% confidence interval, 2.27-50.32; P = 0.003). Notably, 27 (33%) of 83 swabs from women reporting 100% condom usage were positive for Yc DNA. HIV DNA was only detected in swabs collected postseroconversion. CONCLUSIONS: The use of Yc DNA in HIV prevention trials could reliably identify subgroups of women who have unprotected sexual activity and could provide valuable exposure-based estimates of efficacy.
BACKGROUND: The inability to quantify sexual exposure to HIV limits the power of HIV prevention trials of vaccines, microbicides, and preexposure prophylaxis in women. We investigated the detection of HIV-1 and Y chromosomal (Yc) DNA in vaginal swabs from 83 participants in the HPTN 035 microbicide trial as biomarkers of HIV exposure and unprotected sexual activity. METHODS: One hundred forty-three vaginal swabs from 85 women were evaluated for the presence of Yc DNA (Quantifiler Duo DNA quantification kit; Applied Biosystems) and total HIV-1 DNA (single-copy in-house quantitative polymerase chain reaction assay). Y DNA detection was paired with self-reported behavioral data with regard to recent coitus (≤1 week before collection) and condom usage (100% vs. <100% compliance). RESULTS: Yc DNA was detected in 62 (43%) of 143 swabs. For the 126 visits at which both behavioral data and swabs were collected, Yc DNA was significantly more frequent in women reporting less than 100% condom usage (odds ratio, 10.69; 95% confidence interval, 2.27-50.32; P = 0.003). Notably, 27 (33%) of 83 swabs from women reporting 100% condom usage were positive for Yc DNA. HIV DNA was only detected in swabs collected postseroconversion. CONCLUSIONS: The use of Yc DNA in HIV prevention trials could reliably identify subgroups of women who have unprotected sexual activity and could provide valuable exposure-based estimates of efficacy.
Authors: Johan H Melendez; Julie A Giles; Jeffrey D Yuenger; Tukisa D Smith; Khalil G Ghanem; Karl Reich; Jonathan M Zenilman Journal: Sex Transm Dis Date: 2007-08 Impact factor: 2.830
Authors: Terri L Walsh; Ron G Frezieres; Karen Peacock; Anita L Nelson; Virginia A Clark; Leslie Bernstein; Brian G D Wraxall Journal: Contraception Date: 2003-02 Impact factor: 3.375
Authors: Khalil G Ghanem; Johan H Melendez; Corlina McNeil-Solis; Julie A Giles; Jeffrey Yuenger; Tukisa D Smith; Jonathan Zenilman Journal: Sex Transm Dis Date: 2007-08 Impact factor: 2.830
Authors: H Zhang; G Dornadula; M Beumont; L Livornese; B Van Uitert; K Henning; R J Pomerantz Journal: N Engl J Med Date: 1998-12-17 Impact factor: 91.245
Authors: Margaret Christine Snead; Jeffrey Wiener; Sinmisola Ewumi; Christi Phillips; Lisa Flowers; Tina Hylton-Kong; Natalie Medley-Singh; Jennifer Legardy-Williams; Elizabeth Costenbader; John Papp; Lee Warner; Carolyn Black; Athena P Kourtis Journal: Sex Transm Infect Date: 2017-05-05 Impact factor: 3.519
Authors: Renee Heffron; Randy Stalter; Maria Pyra; Kavita Nanda; David W Erikson; Florian Hladik; Steven W Blue; Nicole L Davis; Nelly Mugo; Athena P Kourtis; Jairam R Lingappa; Jared M Baeten Journal: AIDS Date: 2019-03-15 Impact factor: 4.177
Authors: Maria P Lemos; Erica Lazarus; Abby Isaacs; Janan Dietrich; Cecilia Morgan; Yunda Huang; Doug Grove; Michele Andrasik; Fatima Laher; John Hural; Eva Chung; Joan Dragavon; Adrian Puren; Reena K Gulati; Robert Coombs; Margaret Juliana McElrath; Glenda Gray; James G Kublin Journal: J Acquir Immune Defic Syndr Date: 2019-06-01 Impact factor: 3.731
Authors: Renee Heffron; Urvi M Parikh; Kerri J Penrose; Nelly Mugo; Deborah Donnell; Connie Celum; John W Mellors; Jared M Baeten Journal: AIDS Behav Date: 2017-07
Authors: Maria P Lemos; Vijay Nandi; Joan Dragavon; Ira Fleming; Keertana Krishnan; Martin Musuruana; Madeline Kramer; Hayley Glantz; Michele Andrasik; Robert W Coombs; M Juliana McElrath; Hong-Van Tieu Journal: J Acquir Immune Defic Syndr Date: 2021-10-01 Impact factor: 3.771